Stat Diagnostica announces 25 Million Euros in Series C Financing led by Gilde Healthcare

by Caixa Capital Risc

Led by new investor Gilde Healthcare , the financing round also drew participation from existing investors , including Kurma Partners ; Ysios Capital ; Idinvest Partners ; Boehringer Ingelheim Venture...

Read more

La Caixa leads an investment round in Inbiomotion with the participation of Ysios Capital

by Professional Newco

The company concludes a 2.2 million Euro round led by ”la Caixa” through Caixa Capital Risc. Also participating in the operation were Ysios Capital, which led the first investment round for the co...

Read more

Interview with Josep Lluís Sanfeliu and José Antonio Mesa: 'The first decade of investment in the sector was trial and error, now it’s regeneration and consolidation'

by Biocat

Ysios Capital and Caixa Capital Risc are two of the 25 life sciences investment funds currently operating in the BioRegion of Catalonia. These two funds, Ysios Capital and Caixa Capital Risc, often jo...

Read more

RCD asesora a Aelix Therapeutics en la ronda de financiación de 11,5 millones de euros que se destinarán al desarrollo de una vacuna contra el sida

by RCD

RCD cuenta con amplia experiencia y conocimiento en el asesoramiento a instituciones públicas de investigación y a compañías biotecnológicas, a las que presta un servicio integral en aspectos com...

Read more

Aelix Therapeutics completes Series A funding of € 11.5 M ($ 12.7 M)

by Caixa Capital Risc

The proceeds will support the development of the HTI immunogen as a therapeutic vaccine against HIV infection, up to the completion of a Phase 2 proof-of-concept efficacy trial in HIV-infected individ...

Read more

Minoryx Therapeutics completes Series A funding of €19.4M ($21.7M)

by Ysios Capital

Ysios Capital, a Spanish investment fund, led the round. The fundraising was also supported by a substantial syndicate of new investors including Kurma Partners, Roche Venture Fund, Idinvest Partners ...

Read more

Novedad en los fondos biotecnológicos en España

by Abra Invest

En España se están consolidando un número reducido de inversores de capital riesgo especializados en biotecnología. Algunos de ellos están recibiendo el apoyo de inversores internacionales y otro...

Read more

Ysios logra los primeros 52 millones de su nuevo fondo

by Expansión

“El fondo está orientado a empresas altamente innovadoras, en los campos de productos terapéuticos, diagnóstico y dispositivos médicos para necesidades claramente no cubiertas”, apunta Joël J...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Grupo ONEtoONE desembarca con su fondo d...

by ONEtoONE Corporate Finance

ONEtoONE Asset Management ha realizado su quinta inversión fuera de n...

Photos Stream